ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

Health Organizations Endorse “Patients’ Rights” Document

November 17, 1995

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975

NCI Forms Lung Cancer Program for Research On Early Detection, Treatment.

June 23, 2006

The Cancer Letter takes summer publication break, back Sept. 12.

August 8, 2003

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

October 2, 1992

GM Cancer Research Foundation Awards $750,000 To Five Scientists For Their Work

June 8, 2001